Thus, increasing plasma levels of ApoA1/HDL would be a new interesting strategy for the improvement of the cognitive function in Alzheimer’s disease, although a direct evidence of this is still missing. The gene discussed is APOA1; the disease is early-onset autosomal dominant Alzheimer disease.